{{Rsnum
|rsid=9600079
|Chromosome=13
|position=73154002
|Orientation=plus
|GMAF=0.4394
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 26.8 | 51.8 | 21.4
| HCB | 31.9 | 46.7 | 21.5
| JPT | 43.4 | 42.5 | 14.2
| YRI | 27.9 | 41.5 | 30.6
| ASW | 14.0 | 52.6 | 33.3
| CHB | 31.9 | 46.7 | 21.5
| CHD | 27.5 | 51.4 | 21.1
| GIH | 32.7 | 46.5 | 20.8
| LWK | 36.7 | 48.6 | 14.7
| MEX | 39.7 | 44.8 | 15.5
| MKK | 30.3 | 54.8 | 14.8
| TSI | 16.7 | 54.9 | 28.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20676098
|Trait=None
|Title=Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population
|RiskAllele=T
|Pval=3E-9
|OR=1.18
|ORtxt=[1.12-1.24]
}}

{{PMID Auto
|PMID=22056501
|Title=Replication of five prostate cancer loci identified in an Asian population - Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
|OA=1
}}

{{PMID Auto
|PMID=22114074
|Title=Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium.
|OA=1
}}

{{PMID Auto
|PMID=23405784
|Title=[Susceptibility to prostate cancer in Han Chinese: single nucleotide polymorphism analysis of 1 667 cases]
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}